Trend of Death and Years of Life Lost Caused by Lung Cancer in Handan, 2017-2023.
10.3779/j.issn.1009-3419.2025.106.15
- Author:
Nianzhen FANG
1
;
Yang ZHAO
1
;
Yang YANG
1
Author Information
1. Handan Prefectural Center for Disease Control and Prevention, Handan 056000, China.
- Publication Type:Journal Article
- Keywords:
Cause eliminated life expectancy;
Fulfillment index;
Lung neoplasms;
Potential years of life lost
- MeSH:
Lung Neoplasms/mortality*;
Humans;
Male;
Life Expectancy/trends*;
Female;
China/epidemiology*;
Aged;
Middle Aged;
Aged, 80 and over;
Adult;
Young Adult
- From:
Chinese Journal of Lung Cancer
2025;28(6):427-433
- CountryChina
- Language:Chinese
-
Abstract:
BACKGROUND:Lung cancer ranks as the foremost cause of cancer-related deaths in China, significantly undermining population health and longevity. By analyzing the trends of death and years of life lost caused by lung cancer in Handan from 2017 to 2023, data support is provided for the formulation of prevention and treatment strategies.
METHODS:Lung cancer death data in Handan during 2017-2023 were collected. Excel 2010, SPSS 26.0 and Joinpoint 4.9.0.0 were used to analyze the mortality rate of lung cancer, average annual percentage change (AAPC), cause eliminated life expectancy (CELE), potential gains in life expectancy (PGLEs), Fulfillment index, potential years of life lost (PYLL), potential years of life lost rate (PYLLR), and standardized potential years of life lost rate (SPYLLR).
RESULTS:The standardized mortality rate of lung cancer in Handan from 2017 to 2023 showed a decreasing trend (AAPC=-7.10%, P<0.01). The CELE of lung cancer increased by 2.49 years (AAPC=0.48%, P<0.05). The life loss rate decreased by 21.43% (AAPC=-4.61%, P<0.05). The Fulfillment index by lung cancer increased with the growth of age from 2017 to 2023. The PYLL, PYLLR, standardized potential years of life lost (SPYLL) and SPYLLR of lung cancer during 2017 to 2023 were 134,219.75 person years, 2.03‰, 98,735.63 person years, and 1.49‰, respectively. The annual PYLLR and SPYLLR showed a decreasing trend (AAPC=-6.34%, -9.34%, respectively, P<0.01).
CONCLUSIONS:The standardized mortality rate of lung cancer in Handan from 2017 to 2023 showed a decreasing trend, and the impact of lung cancer on life expectancy decreased. The mortality rates of lung cancer showed significant differences among different ages and genders. It is necessary to take good measures to prevent and control lung cancer in males and higher age groups.
